MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • MDS Virtual Congress 2020

    Differential patterns of gray matter volume in responders and non-responders with Parkinson’s disease after deep brain stimulation

    Y. Lai, P. Huang, C. Zhang, T.o Wang, B. Sun, D. Li (Shanghai, China)

    Objective: To identify the patterns of gray matter volume by voxel-based morphometry (VBM) in responders and non-responders with Parkinson’s disease (PD) after deep brain stimulation…
  • MDS Virtual Congress 2020

    Predictors of the progression of dementia with Lewy bodies

    A. Chimagomedova, O. Levin (Moscow, Russian Federation)

    Objective: To define predictors of the progression of dementia with Lewy bodies (DLB). Background: Dementia with Lewy bodies is a progressive disabling neurodegenerative disease with…
  • MDS Virtual Congress 2020

    The dual cognitive syndrome in Parkinson’s disease: volumetric, morphological and tractometric features

    Q. Devignes, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, G. Carey, L. Defebvre, A. Leentjens, K. Dujardin (Lille, France)

    Objective: To assess volumetric, morphological and tractometric features associated with the fronto-striatal and posterior cortical cognitive profiles in Parkinson’s Disease (PD) Background: The dual syndrome…
  • MDS Virtual Congress 2020

    Visualization of Nigrosome 1 at 3T MRI and 18F-DOPA PET for the diagnosis of Parkinson´s disease

    A. Martin-Bastida, V. Suarez-Vega, P. Dominguez-Echavarri, F. Guillen-Valderrama, I. Aviles-Olmos, J. Arbizu, M. Rodriguez-Oroz (Pamplona, Spain)

    Objective: To determine and compare the utility of Nigrosome 1 at 3T MRI and 18F-DOPA PET for the diagnosis of Parkinson´s disease. Background: Differential diagnosis…
  • MDS Virtual Congress 2020

    Regional free-water differentially associated with glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease

    D. Tosun, R. Ellis (San Francisco, CA, USA)

    Objective: Assess to what extent free-water(FW) as measured by diffusion-weighted MRI(dMRI) is a neuroimaging marker of glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease(PD) patients from…
  • MDS Virtual Congress 2020

    Cerebellar structural covariance networks in young people with Tourette syndrome

    H. Sigurdsson, S. Jackson, L. Jolley, E. Mitchell, G. Jackson (Nottingham, United Kingdom)

    Objective: To investigate discrete structural brain networks in children and adolescents with Tourette syndrome [TS] relative to a group of matched control participants. Background: TS…
  • MDS Virtual Congress 2020

    Defining time and anatomical specificity of basal ganglia white matter loss in premanifest Huntington’s disease

    P. Zeun, P. McColgan, T. Dhollander, S. Gregory, E. Johnson, M. Papoutsi, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

    Objective: To identify when white matter connections first begin to degenerate in HD and which connections are most susceptible to early degeneration. Background: Huntington’s disease…
  • MDS Virtual Congress 2020

    Meynert Nucleus-related Cortical Thinning in Parkinson’s Disease with Mild Cognitive Impairment

    S.M Rong, Y. Li, B. Li, K. Nie, P. Zhang, TT. Cai, M.J Mei, L.J Wang, Y.H Zhang (Guangzhou, China)

    Objective: To investigate the associations between NBM/Ch4 volume and cortical thickness in PD. Background: Cognitive impairment in Parkinson’s disease (PD) involves the cholinergic system, especially the…
  • MDS Virtual Congress 2020

    Quantitative Susceptibility Mapping may help distinguish patients with Parkinson’s disease, progressive supranuclear palsy and multiple system atrophy with predominant parkinsonism

    K. Matsuura, Y. Ii, M. Maeda, K. Tabei, M. Umino, H. Tomimoto, A. Shindo (TSU, Mie, Japan)

    Objective: The purpose of this study was to examine quantitative susceptibility mapping (QSM) changes in PD and multiple system atrophy with predominant parkinsonism (MSA-P) and…
  • MDS Virtual Congress 2020

    Brain atrophy progression in de novo Parkinson’s disease

    C. Tremblay, S. Rahayel, A. Vo, A. Dagher (Montreal, QC, Canada)

    Objective: Using deformation-based morphometry (DBM) as a measure of atrophy, the aim of this study was to identify the regions presenting structural brain changes after…
  • « Previous Page
  • 1
  • …
  • 50
  • 51
  • 52
  • 53
  • 54
  • …
  • 88
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley